We explored that with age over 60, KMT2D, PIM1, and CREBBP were frequently mutated in EBV-negative patients, while MYD88, ID3, and FOXO1 highly altered in EBV+ DLBCL group. Here, FOXO1 is linked to diffuse large B-cell lymphoma.